G2MC Flagship Projects
Developing strategies for implementing pharmacogenomics data and best practices into clinical use.
George Patrinos (Greece)
The Pharmacogenomics Flagship Project aims to develop strategies for the collection, storing, and sharing of pharmacogenomics (PGx) data, as well as develop and implement PGx best practices for clinical use.
- Develop data repositories of PGx variants in diverse populations around the world.
- Develop a strategy to engage PIs and young investigators from low and middle-income countries in PGx research and clinical implementation.
- January 2021 Update: The Pharmacogenomics Flagship Project has been exploring opportunities with the Evidence Working Group on ways to demonstrate existing evidence in the field of pharmacogenomics. Additionally, the project will focus efforts on the need for generating harmonized guidelines for pharmacogenomics in clinical use – an area that is already under exploration but can potentially be advanced further through the efforts of the flagship project group. These initiatives will be discussed further during the January 21 Pharmacogenomics Flagship Project Breakout Session.
View the G2MC Publications webpage for a list of publications either written by G2MC members or relevant to the G2MC organization.
G2MC members are invited to join us throughout the weeks of January 19-29, 2021, and on February 2, 2021, for the G2MC Semi-Annual Virtual Working Group and Flagship Project Breakout sessions, designed to move G2MC projects and initiatives forward through the collaboration and input of G2MC members.